Coronavirus (COVID-19) Nucleocapsid Antibody
Catalog Number:
ABI-11-2003-25
- Images (3)
| Article Name: | Coronavirus (COVID-19) Nucleocapsid Antibody |
| Biozol Catalog Number: | ABI-11-2003-25 |
| Supplier Catalog Number: | 11-2003-25 |
| Alternative Catalog Number: | ABI-11-2003-25-25UG |
| Manufacturer: | Abeomics |
| Host: | Rabbit |
| Category: | Antikörper |
| Application: | ELISA, WB |
| Immunogen: | A partial length recombinant coronavirus Nucleocapsid protein (amino acids 250-410) was used as the immunogen for this antibody. |
| Alternative Names: | covid-19 |
| The structural nucleocapsid (N) protein of nCoV/SARS-CoV-2/COVID-19 is a predicted 46 kDa phosphoprotein having 419 amino acid residues. A short Serine rich stretch and a recognized nuclear localization signal are the unique features of the nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19, which seems to have a little homology with the proteins of other members of this large corona virus family. These features also suggest the involvement of nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19 in different stages of viral lifecycle. The protein has multifaceted activities including packing of the nCoV/SARS-CoV-2/COVID-19 viral genome into a helical ribonucleocapsid (RNP) and playing an important role in viral self-assembly causing nCoV/SARS-CoV-2/COVID-19. The nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19 also forms dimer in the cell by self-association with the help of interactive C terminal domain. |
| Clonality: | Polyclonal |
| Purity: | Protein A Chromatography |
| Form: | Purified |
| Target: | coronavirus Nucleocapsid protein |
| Application Dilute: | Recommended dilutions: WB: 0.5-1 µg/ml. However, this need to be optimized based on the research applications. |
|
|
Figure-1: Wells of a 96-microtiter plate were coated with 4ug/ml of SARS-Cov-2/nCov/COVID-19 Nucleocapsid recombinant protein (21-1003). The binding was detected by addition of different dilution of 11-2003 polyclonal antibody. The reactivity was detected by a HRP-conjugated goat-anti-rabbit polyclonal antibody. |
|
|
Figure-2: Western Blot analysis of SARS-CoV-2 Nucleocapsid Protein: Anti- SARS-CoV-2 Nucleocapsid Protein (11-2003) was used at 2 µg/ml on (1) SARS-CoV-2 virus infected Vero Cell lysate and (2) Mock infected lysate. |
|
|
Figure-3: Western Blot analysis of Nucleocapsid antibody: Anti- Nucleocapsid antibody (SARS-CoV-2) was used at 4 µg/ml on recombinant Nucleocapsid Protein (21-1003). |
Product Guarantee and Expert Support
